Hyperactivation of MYC initiates tumor-induced immune suppression through crosstalk between tumor cells and different immune cell subsets in the TME, such as T cells, B cells, macrophages, natural killer cells, dendritic cells (DCs), and neutrophils (Fig. 2). Here, MYC is linked to neoplasm.